Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-24 @ 7:36 PM
NCT ID:
NCT01522703
Eligibility Criteria:
Inclusion Criteria:
* doctor diagnosis of asthma
* aeroallergen sensitization
* Non-smoker
* Negative pregnancy test
* Not breastfeeding
* Normal TSH
* For women, abstinent or using reliable birth control
* Age 18-50 years
* No other major pulmonary disease such as cystic fibrosis or COPD
* Willingness to participate in study and sign consent form
Exclusion Criteria:
* Severe or unstable asthma defined as requiring hospitalization in the previous 6 months or intubation in the previous 2 years, or on high-dose inhaled corticosteroids or chronic oral corticosteroids
* Uncontrolled asthma defined as short-acting beta agonist use 3 or more days a week in the previous 4 weeks
* Other significant medical issues such as heart disease or poorly controlled hypertension, type 1 diabetes, poorly controlled type 2 diabetes, or hypothyroidism
* Pregnancy or nursing/breastfeeding mothers
* On beta-blocker therapy
* On reserpine, clonidine, imipramine, or related tricyclic drugs
* Taking anti-oxidant supplements
* Planned dietary changes during the study period
* Unable to stop antihistamines prior to skin testing
* Food allergy to Broccoli Sprouts or Alfalfa Sprouts
* Omalizumab use within the last 12 months
* Nasal polyps
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01522703
Study Brief:
Protocol Section:
NCT01522703